NAD plus rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis
Rui Zhan,Xia Meng,Dongping Tian,Jie Xu,Hongtu Cui,Jialei Yang,Yangkai Xu,Mingming Shi,Jing Xue,Weiwei Yu,Gaofei Hu,Ke Li,Xiaoxiao Ge,Qi Zhang,Mingming Zhao,Jianyong Du,Xin Guo,Wenli Xu,Yang Gao,Changyu Yao,Fan Chen,Yue Chen,Wenxin Shan,Yujie Zhu,Lian Ji,Bing Pan,Yan Yu,Wenguan Li,Xuyan Zhoa,Qihua He,Xiaohui Liu,Yue Huang,Shengyou Liao,Bin Zhou,Dehua Chui,Y. Eugene Chen,Zheng Sun,Erdan Dong,Yongjun Wang,Lemin Zheng
DOI: https://doi.org/10.1016/j.neuron.2023.08.010
IF: 16.2
2023-01-01
Neuron
Abstract:Blood-brain barrier (BBB) function deteriorates during aging, contributing to cognitive impairment and neuro-degeneration. It is unclear what drives BBB leakage in aging and how it can be prevented. Using single -nu-cleus transcriptomics, we identified decreased connexin 43 (CX43) expression in cadherin-5+ (Cdh5+) cerebral vascular cells in naturally aging mice and confirmed it in human brain samples. Global or Cdh5+ cell-specific CX43 deletion in mice exacerbated BBB dysfunction during aging. The CX43-dependent effect was not due to its canonical gap junction function but was associated with reduced NAD+ levels and mitochondrial dysfunc-tion through NAD+-dependent sirtuin 3 (SIRT3). CX43 interacts with and negatively regulates poly(ADP-ribose) polymerase 1 (PARP1). Pharmacologic inhibition of PARP1 by olaparib or nicotinamide mononucleotide (NMN) supplementation rescued NAD+ levels and alleviated aging-associated BBB leakage. These findings establish the endothelial CX43-PARP1-NAD+ pathway's role in vascular aging and identify a potential thera-peutic strategy to combat aging-associated BBB leakage with neuroprotective implications.